Don't Just Read the News, Understand It.
Published loading...Updated

Has ProPhase Labs (PRPH) Outpaced Other Medical Stocks This Year?

Summary by Ground News
ProPhase Labs, Inc. (PRPH) is one of 1184 individual stocks in the Medical sector. Collectively, these companies sit at #8 in the Zacks Sector Rank. The Zacks Consensus Estimate for PRPH's full-year earnings has moved 107.6% higher within the past quarter.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Zacks Investment Research broke the news in on Thursday, May 26, 2022.
Sources are mostly out of (0)

You have read 1 out of your 5 free daily articles.

Join millions of well-informed readers who use Ground to compare coverage, check their news blindspots, and challenge their worldview.